![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Body Fat Distribution Changes After 96 Weeks of Therapy with Lopinavir/ritonavir (LPV/r) Plus Raltegravir (RAL) Compared with LPV/r Plus Tenofovir/Emtricitabine (TDF/FTC) in Antiretroviral (ARV)-Naïve, HIV-1-Infected Subjects from the PROGRESS Study
|
|
|
Reported by Jules Levin
13th European AIDS Conference
12-14 October 2011-Belgrade, Serbia
Jean van Wyk1, Pere Domingo2, Linda Fredrick1, Min Tian1, Brad Saget1, Roger Trinh1, Michael Norton1
1. Abbott, Abbott Park, Illinois
2. Hospital de la Santa Creu I Sant Pau, Barcelona, Spain
![EACS1.gif](../images/101711/101711-5/EACS1.gif)
![EACS2.gif](../images/101711/101711-5/EACS2.gif)
![EACS3.gif](../images/101711/101711-5/EACS3.gif)
![EACS4.gif](../images/101711/101711-5/EACS4.gif)
![EACS5.gif](../images/101711/101711-5/EACS5.gif)
![EACS6.gif](../images/101711/101711-5/EACS6.gif)
![EACS7.gif](../images/101711/101711-5/EACS7.gif)
![EACS8.gif](../images/101711/101711-5/EACS8.gif)
![EACS9.gif](../images/101711/101711-5/EACS9.gif)
![EACS10.gif](../images/101711/101711-5/EACS10.gif)
![EACS11.gif](../images/101711/101711-5/EACS11.gif)
![EACS12.gif](../images/101711/101711-5/EACS12.gif)
![EACS13.gif](../images/101711/101711-5/EACS13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|